Demographic, clinical, and cognitive characteristics of T2DM patients and healthy control subjects.<sup>*</sup>

<p>*Data are presented as the mean ± SD unless otherwise noted; ** <i>p</i><0.05.</p><p>T2DM, type 2 diabetes mellitus; BMI, body mass index; HbA1c, glycated hemoglobin; HOMA2-S%, homeostasis model assessment for insulin sensitivity; ABI, ankle-brachial index; UACR, urine albumin creatinine ratio; MMSE, Mini Mental State Exam; MoCA, Montreal Cognitive Assessment; CDT, clock drawing test; MRI, magnetic resonance imaging; SVD, small vessel disease; WMLs, white matter lesions (these were assessed in both hemispheres using the Wahlund age-related white matter changes scale <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0108883#pone.0108883-Wahlund1" target="_blank">[40]</a>).</p><p>Demographic, clinical, and cognitive characteristics of T2DM patients and healthy control subjects.<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0108883#nt101" target="_blank">*</a></sup></p>